Literature DB >> 23774203

Three-dimensional spine parameters can differentiate between progressive and nonprogressive patients with AIS at the initial visit: a retrospective analysis.

Marie-Lyne Nault1, Jean-Marc Mac-Thiong, Marjolaine Roy-Beaudry, Jacques deGuise, Hubert Labelle, Stefan Parent.   

Abstract

BACKGROUND: Knowledge concerning morphology of the spine is reported in 2-dimensional (2D) or focuses on modification of parameters with progression of spinal deformation. The objective of this study was to compare 3-dimensional (3D) morphologic parameters of the spine at the first visit between progressive and a nonprogressive group of immature adolescent idiopathic scoliosis (AIS).
METHODS: The first group was made up of surgically corrected AIS patients (E) (n=19), whereas the second group was composed of nonprogressive AIS that had reached skeletal maturity (n=18). Computerized measurements were undertaken on reconstructed 3D spines. There were 5 categories of measurement: Cobb angles (scoliosis, kyphosis, lordosis), 3D wedging (apical vertebra, mean 2 apical disks), rotation (upper and lower junctional vertebra, apical vertebra, and disk), torsion, and slenderness (height/width ratio of T6, L4, and T1-L5). Nonparametric Mann-Whitney tests were also undertaken.
RESULTS: There was no statistical difference between the 2 groups for age, 3D Cobb angle, lordosis, and kyphosis. Mean 3D wedging of the apical disks, lower junctional vertebral axial rotation, torsion and T6, and whole spine height/width ratio were all significantly affected.
CONCLUSIONS: This study supports the theory that wedging begins in the disks and then in the vertebral body and identifies 3D morphologic parameters that could be used in the prediction of AIS evolution. The findings in the junctional area illustrate that a torsional deformity seems to occur distally from the apex and creates a progressive scoliosis. Curve progression could be predicted based on 3D morphometric parameters, as early as the initial visit.

Entities:  

Mesh:

Year:  2013        PMID: 23774203     DOI: 10.1097/BPO.0b013e318292462a

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  Predicting success or failure of brace treatment for adolescents with idiopathic scoliosis.

Authors:  Eric Chalmers; Lindsey Westover; Johith Jacob; Andreas Donauer; Vicky H Zhao; Eric C Parent; Marc J Moreau; James K Mahood; Douglas M Hedden; Edmond H M Lou
Journal:  Med Biol Eng Comput       Date:  2015-05-23       Impact factor: 2.602

2.  Three-dimensional reconstruction using stereoradiography for evaluating adult spinal deformity: a reproducibility study.

Authors:  Emmanuelle Ferrero; Renaud Lafage; Shaleen Vira; Pierre-Yves Rohan; Jonathan Oren; Edward Delsole; Pierre Guigui; Frank Schwab; Virginie Lafage; Wafa Skalli
Journal:  Eur Spine J       Date:  2016-11-05       Impact factor: 3.134

Review 3.  Scoliosis and Prognosis-a systematic review regarding patient-specific and radiological predictive factors for curve progression.

Authors:  Maximilian Lenz; Stavros Oikonomidis; Arne Harland; Philipp Fürnstahl; Mazda Farshad; Jan Bredow; Peer Eysel; Max Joseph Scheyerer
Journal:  Eur Spine J       Date:  2021-03-26       Impact factor: 3.134

4.  Differences in vertebral morphology around the apical vertebrae between neuromuscular scoliosis and idiopathic scoliosis in skeletally immature patients: a three-dimensional morphometric analysis.

Authors:  Takahiro Makino; Yusuke Sakai; Masafumi Kashii; Shota Takenaka; Kazuomi Sugamoto; Hideki Yoshikawa; Takashi Kaito
Journal:  BMC Musculoskelet Disord       Date:  2017-11-16       Impact factor: 2.362

5.  Three-dimensional spinal morphology can differentiate between progressive and nonprogressive patients with adolescent idiopathic scoliosis at the initial presentation: a prospective study.

Authors:  Marie-Lyne Nault; Jean-Marc Mac-Thiong; Marjolaine Roy-Beaudry; Isabelle Turgeon; Jacques Deguise; Hubert Labelle; Stefan Parent
Journal:  Spine (Phila Pa 1976)       Date:  2014-05-01       Impact factor: 3.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.